Louisbourg Investments’s Pfizer PFE Stock Holding History

Louisbourg Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41K	Sell	100 -1,600	-94%	-$41.9K	﹤0.01%	192
2026 Q1	$47.7K	Hold	1,700	–	–	0.01%	154
2025 Q4	$42.3K	Hold	1,700	–	–	0.01%	149
2025 Q3	$43.3K	Hold	1,700	–	–	0.01%	144
2025 Q2	$41.2K	Hold	1,700	–	–	0.01%	132
2025 Q1	$43.1K	Hold	1,700	–	–	0.01%	127
2024 Q4	$45.1K	Hold	1,700	–	–	0.01%	123
2024 Q3	$49.2K	Hold	1,700	–	–	0.01%	122
2024 Q2	$47.6K	Hold	1,700	–	–	0.01%	119
2024 Q1	$47.2K	Hold	1,700	–	–	0.01%	120
2023 Q4	$48.9K	Buy	+1,700	New	+$51.4K	0.01%	119

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Louisbourg Investments's PFE Position: Q2 2026 in Review

Louisbourg Investments reduced its Pfizer (PFE) stake by 94% in Q2 2026, selling an estimated $41.9K and leaving 100 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #192.

Louisbourg Investments first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $49.2K in Q3 2024. 1,257 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Louisbourg Investments held 100 shares of Pfizer worth $2.41K as of Q2 2026.
Louisbourg Investments sold 1,600 Pfizer shares in Q2 2026, an estimated $41.9K.
Pfizer made up ﹤0.01% of Louisbourg Investments's portfolio in Q2 2026, its #192 holding.
Louisbourg Investments first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Louisbourg Investments's Pfizer position peaked at $49.2K in Q3 2024.
1,257 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Louisbourg Investments's 13F filing for Q2 2026, filed 23 Jul 2026.